{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:03:54Z","timestamp":1789682634264,"version":"4.0.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jhep.2026.04.011","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:44:07Z","timestamp":1777495447000},"page":"18-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-TNF therapies in autoimmune hepatitis: Promises and challenges"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0104-465X","authenticated-orcid":false,"given":"Marte Lie","family":"H\u00f8ivik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.jhep.2026.04.011_bib1","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","article-title":"Cytokines in alcoholic and nonalcoholic steatohepatitis","volume":"343","author":"Tilg","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.011_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00281-022-00910-2","article-title":"TNF in the liver: targeting a central player in inflammation","volume":"44","author":"Tiegs","year":"2022","journal-title":"Semin Immunopathol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.011_bib3","first-page":"93","article-title":"Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages\/neutrophils: protective and deleterious effects","volume":"22","author":"Grivennikov","year":"2005","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.011_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/hep.22914","article-title":"Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells","volume":"50","author":"Longhi","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.011_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clim.2012.10.008","article-title":"TNF-\u03b1 is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression","volume":"146","author":"Iwamoto","year":"2013","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.011_bib6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12041-013-0272-9","article-title":"Tumour necrosis factor alpha (TNF-\u03b1) genetic polymorphisms and the risk of autoimmune liver disease: a meta-analysis","volume":"92","author":"Li","year":"2013","journal-title":"J Genet"},{"issue":"12","key":"10.1016\/j.jhep.2026.04.011_bib7","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.1900124","article-title":"TNF-producing Th1 cells are selectively expanded in liver infiltrates of patients with autoimmune hepatitis","volume":"203","author":"Bovensiepen","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2026.04.011_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.688066","article-title":"Role of Th22 cells in the pathogenesis of autoimmune diseases","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.011_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jhep.2026.02.026","article-title":"Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitis","volume":"85","author":"Xu","year":"2026","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.011_bib10","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","article-title":"EASL Clinical Practice Guidelines on the management of autoimmune hepatitis","volume":"83","year":"2025","journal-title":"J Hepatol"},{"issue":"Suppl 2","key":"10.1016\/j.jhep.2026.04.011_bib11","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2024-334395","article-title":"British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025","volume":"74","author":"Moran","year":"2025","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.jhep.2026.04.011_bib12","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ecco-jcc\/jjae091","article-title":"ECCO guidelines on therapeutics in crohn\u2019s disease: medical treatment","volume":"18","author":"Gordon","year":"2024","journal-title":"J Crohns Colitis"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.011_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.011_bib14","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1097\/HEP.0000000000001089","article-title":"Efficacy and safety of infliximab in patients with autoimmune hepatitis","volume":"81","author":"Efe","year":"2025","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.011_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cgh.2019.02.044","article-title":"Comparative risk of serious infections with biologic and\/or immunosuppressive therapy in patients with inflammatory bowel diseases: a systematic review and meta-analysis","volume":"18","author":"Singh","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.011_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/2050640619889763","article-title":"Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines","volume":"8","author":"Wisniewski","year":"2020","journal-title":"United Eur Gastroenterol J"},{"issue":"9613","key":"10.1016\/j.jhep.2026.04.011_bib17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(08)60304-9","article-title":"Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn\u2019s disease: an open randomised trial","volume":"371","author":"D\u2019Haens","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jhep.2026.04.011_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S2468-1253(24)00034-7","article-title":"A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn\u2019s disease (PROFILE): a multicentre, open-label randomised controlled trial","volume":"9","author":"Noor","year":"2024","journal-title":"The Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.011_bib19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.14218\/JCTH.2021.00243","article-title":"Hepatotoxicity induced by biological agents: clinical features and current controversies","volume":"10","author":"Hernandez","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.011_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102460","article-title":"Characterization of auto-immune hepatitis associated with the use of anti-TNF\u03b1 agents: an analysis of 389 cases in VigiBase","volume":"19","author":"Vollmer","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.jhep.2026.04.011_bib21","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.cgh.2018.04.033","article-title":"Incidence of hepatitis B virus reactivation and hepatotoxicity in patients receiving long-term treatment with tumor necrosis factor antagonists","volume":"16","author":"Pauly","year":"2018","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782600214X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882782600214X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T16:32:33Z","timestamp":1783787553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882782600214X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S016882782600214X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.04.011","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-TNF therapies in autoimmune hepatitis: Promises and challenges","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.02.026","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}